Riverhead Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $151K | Buy |
11,673
+300
| +3% | +$3.88K | 0.01% | 1224 |
|
|
2019
Q2 | $142K | Hold |
11,373
| – | – | 0.01% | 1261 |
|
|
2019
Q1 | $165K | Buy |
11,373
+100
| +0.9% | +$1.45K | 0.01% | 1203 |
|
|
2018
Q4 | $124K | Buy |
11,273
+3,400
| +43% | +$37.4K | 0.01% | 1241 |
|
|
2018
Q3 | $207K | Buy |
7,873
+1,100
| +16% | +$28.9K | 0.01% | 1195 |
|
|
2018
Q2 | $139K | Hold |
6,773
| – | – | 0.01% | 1241 |
|
|
2018
Q1 | $123K | Hold |
6,773
| – | – | 0.01% | 1276 |
|
|
2017
Q4 | $94K | Buy |
6,773
+500
| +8% | +$6.94K | ﹤0.01% | 1363 |
|
|
2017
Q3 | $116K | Buy |
6,273
+1,879
| +43% | +$34.7K | 0.01% | 1235 |
|
|
2017
Q2 | $74K | Buy |
4,394
+2,294
| +109% | +$38.6K | ﹤0.01% | 1323 |
|
|
2017
Q1 | $28K | Sell |
2,100
-400
| -16% | -$5.33K | ﹤0.01% | 1416 |
|
|
2016
Q4 | $38K | Hold |
2,500
| – | – | ﹤0.01% | 1304 |
|
|
2016
Q3 | $29K | Sell |
2,500
-2,975
| -54% | -$34.5K | ﹤0.01% | 1321 |
|
|
2016
Q2 | $1.04M | Sell |
5,475
-6,900
| -56% | -$1.31M | 0.03% | 424 |
|
|
2016
Q1 | $114K | Sell |
12,375
-4,125
| -25% | -$38K | ﹤0.01% | 1325 |
|
|
2015
Q4 | $245K | Buy |
16,500
+11,700
| +244% | +$174K | ﹤0.01% | 1209 |
|
|
2015
Q3 | $79K | Buy |
+4,800
| New | +$79K | ﹤0.01% | 1171 |
|